AI Article Synopsis
- The concept of 'theranostic' involves using the same radioligand to diagnose and treat by targeting the same receptor, either at the same time or separately.
- Recent advancements have led to the development of several effective theranostic tracers in nuclear medicine.
- This review specifically discusses targeted radiopharmaceuticals that are used for both imaging and treating breast cancer.
Article Abstract
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125561 | PMC |
| http://dx.doi.org/10.3390/ijms22094597 | DOI Listing |
Publication Analysis
Top Keywords
breast cancer
8
nuclear medicine
8
theranostic advances
4
advances breast
4
cancer nuclear
4
medicine implication
4
implication 'theranostic'
4
'theranostic' refers
4
refers targeting
4
targeting identical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!